Facilitated By

San Antonio Medical Foundation

A PROSPECTIVE, MULTICENTER, OPEN-LABEL, RANDOMIZED, COMPARATIVE STUDY TO ESTIMATE THE SAFETY, TOLERABILITY, PHARMOKINETICS, AND EFFICACY OF ORAL SCY-078 VS. STANDARD-OF-CARE FOLLOWING INITIAL INTRAVENOUS MICAFUNGIN THERAPY IN THE TREATMENT OF INVASIVE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Cadena Zuluaga,Jose A.
Funded by
SCYNEXIS
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Infectious Disease